nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
An adjusted ELISpot-based immunoassay for evaluation of SARS-CoV-2-specific T-cell responses
|
Lin, Hao |
|
|
4 |
3 |
p. 179-185 |
artikel |
2 |
Application of animal models to compare and contrast the virulence of current and future potential SARS-CoV-2 variants
|
Ding, Zhe |
|
|
4 |
3 |
p. 154-160 |
artikel |
3 |
Assessing the risk of spread of Zika virus under current and future climate scenarios
|
Xu, Ye |
|
|
4 |
3 |
p. 193-204 |
artikel |
4 |
Constructive strategies for drug delivery systems in antivirus disease therapy by biosafety materials
|
Wang, Li |
|
|
4 |
3 |
p. 161-170 |
artikel |
5 |
Genetic differentiation and diversity of SARS-CoV-2 Omicron variant in its early outbreak
|
Weng, Shenghui |
|
|
4 |
3 |
p. 171-178 |
artikel |
6 |
Importation of SARS-CoV-2 Omicron variant in Beijing, China
|
Li, Fu |
|
|
4 |
3 |
p. 150-153 |
artikel |
7 |
Long-term asymptomatic SARS-CoV-2 infection associated with deficiency on multiple immune cells
|
He, Gang |
|
|
4 |
3 |
p. 205-208 |
artikel |
8 |
Omicron variant of SARS-CoV-2 imposes a new challenge for the global public health
|
Xu, Zepeng |
|
|
4 |
3 |
p. 147-149 |
artikel |
9 |
Screening for inhibitors against SARS-CoV-2 and its variants
|
Yuan, Weijing |
|
|
4 |
3 |
p. 186-192 |
artikel |